Status:
WITHDRAWN
Corneal Crosslinking in Keratoconus and Corneal Ectasia
Lead Sponsor:
Ohio State University
Conditions:
Progressive Keratoconus
Corneal Ectasia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Prospective, randomized, single site to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes progressive keratoconus or corn...
Detailed Description
After epithelial surface removal riboflavin drops are applied until there is saturation of the cornea.Then the UVA light is turned on to active the crosslinking process while drops are continued for t...
Eligibility Criteria
Inclusion
- Diagnosis of keratoconus with documented progression over the previous 12 months.
- Diagnosis of corneal ectasia
- Must be able to complete all study visits.
Exclusion
- Prior corneal surgery in keratoconus group
- Corneal scarring
- Pregnancy
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00679666
Start Date
April 1 2008
End Date
October 1 2010
Last Update
April 20 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University Medical Center
Columbus, Ohio, United States, 43210
2
OSU Havener Eye Institute
Dublin, Ohio, United States, 43016